CYSTAGON Side Effects

7023239-8 | Laboratory Test Interference, Leukopenia, Neutropenia
on Sep 20, 2010 Male patient from FRANCE , child 12 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: laboratory test interference, leukopenia, neutropenia. Cystagon dosage: . During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), GENOTROPIN (View Genotropin Review and Genotropin Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

7023216-7 | Benign Intracranial Hypertension, Gait Disturbance, Multiple Epiphyseal Dysplasia, Muscle Contracture
Patient was taking Cystagon (View Usage). Patient had the following side effects: benign intracranial hypertension, gait disturbance, multiple epiphyseal dysplasia, muscle contracture on Sep 20, 2010 from FRANCE Additional patient health information: Male patient , child 3 years of age, was diagnosed with cystinosis and. Cystagon dosage: . During the same period patient was treated with SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), L CARNITINE (View L-carnitine Review and L-carnitine Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), SODIUM PHOSPHATE W/SODIUM PHOSPHATE DIBASIC (View Sodium Phosphate W/sodium Phosphate Dibasic Review and Sodium Phosphate W/sodium Phosphate Dibasic Label ). Patient was hospitalized and became disabled.

7000458-8 | Leukopenia, Neutropenia
Adverse event was reported on Sep 10, 2010 by a Male patient taking Cystagon (View Usage) (Dosage: ) was diagnosed with cystinosis and. Location: FRANCE , child 12 years of age, After Cystagon was administered, patient had the following side effects: leukopenia, neutropenia. During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), GENOTROPIN (View Genotropin Review and Genotropin Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

6785966-7 | Leukopenia, Neutropenia
on Jun 10, 2010 Male patient from FRANCE , child 12 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia. Cystagon dosage: . During the same period patient was treated with NEORECORMON (View Neorecormon Review and Neorecormon Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), GENOTROPIN (View Genotropin Review and Genotropin Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).


6662234-5 | Systemic Lupus Erythematosus
on Mar 18, 2010 Male patient from FRANCE , 14 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: systemic lupus erythematosus. Cystagon dosage: .

6255906-8 | Non-hodgkin's Lymphoma
Patient was taking Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: non-hodgkin's lymphoma on Jun 22, 2009 from FRANCE Additional patient health information: Male patient , 24 years of age, was diagnosed with cystinosis and. Cystagon dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ).

6202924-1 | Non-hodgkin's Lymphoma, Tracheostomy
Adverse event was reported on May 06, 2009 by a Male patient taking Cystagon (View Usage) (Dosage: Dailyp; Oral, 350 Mg; 4 Tims A Day; Oral) was diagnosed with cystinosis and. Location: FRANCE , 24 years of age, Patient experienced the following unwanted or unexpected effects: non-hodgkin's lymphoma, tracheostomy. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ).

5940491-8 | Abdominal Pain Upper, Dialysis, Parosmia, Renal Failure, Transplant Failure
on Oct 15, 2008 Female patient from FRANCE , 24 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: abdominal pain upper, dialysis (What is dialysis?), parosmia, renal failure, transplant failure. Cystagon dosage: 43 Mg/kg;daily; 48 Mg/kg;daily; 51 Mg/kg;daily;. Patient was hospitalized.

5893023-7 | Peritonitis, Vomiting
on Sep 05, 2008 Female patient from FRANCE , 18 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: peritonitis, vomiting. Cystagon dosage: Oral; 40 Mg/kg Daily Oral. During the same period patient was treated with KALINOR (View Kalinor Review and Kalinor Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), EPOGEN (View Epogen Review and Epogen Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SHOHL'S (View Shohl's Review and Shohl's Label ).

5818513-4 | Renal Cell Carcinoma
Patient was taking Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: renal cell carcinoma on Jul 03, 2008 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with cystinosis and. Cystagon dosage: 600 Mg; 4 Times A Day; Oral. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), CYSTEAMINE (View Cysteamine Review and Cysteamine Label ).

5798974-X | Papillary Tumour Of Renal Pelvis, Renal Cell Carcinoma, Renal Failure Chronic, Renal Mass
Adverse event was reported on Jun 16, 2008 by a Male patient taking Cystagon (View Usage) (Dosage: 600 Mg;4 Times A Day;oral) was diagnosed with cystinosis and. Location: UNITED STATES , 18 years of age, Patient had the following side effects: papillary tumour of renal pelvis, renal cell carcinoma, renal failure chronic, renal mass. During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), CYSTEAMINE (View Cysteamine Review and Cysteamine Label ).

5755476-4 | Acute Coronary Syndrome
on May 13, 2008 Male patient from FRANCE , 28 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: acute coronary syndrome. Cystagon dosage: . Patient was hospitalized.

5635849-0 | Anuria, Blood Creatinine Increased, Blood Potassium Increased, Blood Urea Increased, Coma, Convulsion, Electroencephalogram Abnormal, Tachycardia
on Feb 11, 2008 Male patient from FRANCE , child 11 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, blood creatinine increased, blood potassium increased, blood urea increased, coma, convulsion, electroencephalogram abnormal, tachycardia. Cystagon dosage: 1600 Mg, 100 Mg; 4 Times A Day, 200 Mg; 4 Times A Day. During the same period patient was treated with CALCIDIA (View Calcidia Review and Calcidia Label ), EPOGEN (View Epogen Review and Epogen Label ), HUMAN GROWTH HORMONE RECOMBINANT (View Human Growth Hormone Recombinant Review and Human Growth Hormone Recombinant Label ), 1 ALPHA (View 1-alpha Review and 1-alpha Label ), POTASSIUM BICARBONATE (View Potassium Bicarbonate Review and Potassium Bicarbonate Label ). Patient was hospitalized.

5616242-3 | Angiopathy, Gait Disturbance, Haemarthrosis, Scar, Subcutaneous Abscess
Patient was taking Cystagon (View Usage). Patient had the following side effects: angiopathy, gait disturbance, haemarthrosis, scar (What is scar?), subcutaneous abscess on Jan 21, 2008 from FRANCE Additional patient health information: Male patient , child 8 years of age, weighting 45.64 lb, was diagnosed with cystinosis and. Cystagon dosage: 200 Mg; 4 Times A Day; Oral, 250 Mg; 4 Times A Day; Oral. During the same period patient was treated with ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ), INDOCID /00003801/ (View Indocid /00003801/ Review and Indocid /00003801/ Label ), PHOSPHONEUROS (View Phosphoneuros Review and Phosphoneuros Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), LOXEN (View Loxen Review and Loxen Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LEVOCARNIL (View Levocarnil Review and Levocarnil Label ).

5615916-8 | Blood Parathyroid Hormone Increased, Haemodialysis, Haemoglobin Decreased, Laboratory Test Abnormal, Peritoneal Dialysis, Peritoneal Disorder
Adverse event was reported on Jan 17, 2008 by a Male patient taking Cystagon (View Usage) (Dosage: Daily; Oral) was diagnosed with cystinosis and. Location: FRANCE , 21 years of age, After Cystagon was administered, patient had the following side effects: blood parathyroid hormone increased, haemodialysis, haemoglobin decreased, laboratory test abnormal, peritoneal dialysis, peritoneal disorder. During the same period patient was treated with TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ). Patient was hospitalized.

5572338-6 | Angiopathy, Haemarthrosis, Scar, Subcutaneous Abscess
on Dec 10, 2007 Male patient from FRANCE , child 8 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: angiopathy, haemarthrosis, scar (What is scar?), subcutaneous abscess. Cystagon dosage: ; Daily; Oral, 10 Mg/kg; 4 Times A Day; Oral. During the same period patient was treated with ALPHACALCIDOL (View Alphacalcidol Review and Alphacalcidol Label ), INDOCID /00003801/ (View Indocid /00003801/ Review and Indocid /00003801/ Label ).

5536681-9 | Dysphagia, Pneumonia, Pneumonia Aspiration, Sepsis, Treatment Noncompliance
on Dec 03, 2007 Male patient from SPAIN , 20 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: dysphagia, pneumonia (What is pneumonia?), pneumonia aspiration, sepsis (What is sepsis?), treatment noncompliance. Cystagon dosage: Oral ; 1800 Mg;daily;oral. Patient was hospitalized.

5531311-4 | Arthralgia, Blood Creatinine Increased, Impetigo, Joint Stiffness, Osteonecrosis
Patient was taking Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: arthralgia, blood creatinine increased, impetigo (What is impetigo?), joint stiffness, osteonecrosis (What is osteonecrosis?) on Nov 14, 2007 from FRANCE Additional patient health information: Male patient , child 10 years of age, was diagnosed with cystinosis and. Cystagon dosage: Daily; Oral; 19.4 Mg/kg; Daily; Oral; 36 Mg/kg; Daily; Oral; 5400 Mg; Daily; Oral. During the same period patient was treated with ERYTHROPOETIN (View Erythropoetin Review and Erythropoetin Label ), PHOSPHATE (View Phosphate Review and Phosphate Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), HGH (View Hgh Review and Hgh Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ).

5455010-2 | Haemorrhage, Lymphoma, Ovarian Cancer, Peritoneal Disorder, Stem Cell Transplant
Adverse event was reported on Aug 30, 2007 by a Female patient taking Cystagon (View Usage) (Dosage: 150 Mg; Oral) was diagnosed with cystinosis and. Location: FRANCE , 19 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhage, lymphoma (What is lymphoma?), ovarian cancer, peritoneal disorder, stem cell transplant. During the same period patient was treated with IMMUNOSUPPRESSIVE AGENTS (View Immunosuppressive Agents Review and Immunosuppressive Agents Label ).

5451863-2 | Impetigo, Joint Stiffness, Osteonecrosis
on Aug 28, 2007 Male patient from FRANCE , child 9 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: impetigo (What is impetigo?), joint stiffness, osteonecrosis (What is osteonecrosis?). Cystagon dosage: Daily;oral, 19.4 Mg/kg;daily;oral, 36 Mg/kg;daily;oral, Daily;oral.

5412138-0 | Dehydration, Diarrhoea, Gastroenteritis, Nausea, Oesophagitis
on Aug 03, 2007 Male patient from FRANCE , child 6 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: dehydration, diarrhoea, gastroenteritis (What is gastroenteritis?), nausea (What is nausea?), oesophagitis. Cystagon dosage: See Image. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

5401329-0 | Pneumonia
Patient was taking Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?) on Jul 11, 2007 from FRANCE Additional patient health information: Male patient , 24 years of age, was diagnosed with cystinosis and. Cystagon dosage: Oral; 1800 Mg;daily;oral. Patient was hospitalized.

5389677-4 | Pneumonia
Adverse event was reported on Jun 28, 2007 by a Male patient taking Cystagon (View Usage) (Dosage: See Image) was diagnosed with cystinosis and. Location: FRANCE , 24 years of age, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

5220986-5 | Abasia, Abnormal Behaviour, Agitation, Anaemia, Arthralgia, Asthenia, Attention Deficit/hyperactivity Disorder, Biopsy Skin Abnormal, Blood Parathyroid Hormone Decreased
on Jan 08, 2007 Male patient from FRANCE , child 10 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: abasia, abnormal behaviour, agitation, anaemia, arthralgia, asthenia, attention deficit/hyperactivity disorder, biopsy skin abnormal, blood parathyroid hormone decreased. Cystagon dosage: See Image. During the same period patient was treated with CYSTEAMINE/00492501/ (MERCAPTURINE) (See Image) (View Cysteamine/00492501/ (mercapturine) Review and Cysteamine/00492501/ (mercapturine) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HUMAN GROWTH HORMONE RECOMBINANT (View Human Growth Hormone Recombinant Review and Human Growth Hormone Recombinant Label ), EPOGEN (View Epogen Review and Epogen Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), L CARNITHINE (View L-carnithine Review and L-carnithine Label ).

5062391-0 | Skin Lesion, Skin Striae
on Jul 06, 2006 Male patient from FRANCE , 15 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: skin lesion, skin striae. Cystagon dosage: See Image. During the same period patient was treated with ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), SOMATROPIN (View Somatropin Review and Somatropin Label ), FERRIC FUMARATE (View Ferric Fumarate Review and Ferric Fumarate Label ), POTASSIUM BICARBONATE (View Potassium Bicarbonate Review and Potassium Bicarbonate Label ), L CARNITHINE (View L-carnithine Review and L-carnithine Label ).

4991303-0 | Venoocclusive Liver Disease
Patient was taking Cystagon (View Usage). Patient had the following side effects: venoocclusive liver disease on Apr 13, 2006 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, was diagnosed with cystinosis and. Cystagon dosage: Oral.

4991256-5 | Portal Hypertension, Splenomegaly, Treatment Noncompliance, Varices Oesophageal, Vein Disorder
Adverse event was reported on Apr 13, 2006 by a Female patient taking Cystagon (View Usage) (Dosage: Oral) was diagnosed with cystinosis and. Location: UNITED STATES , 18 years of age, After Cystagon was administered, patient had the following side effects: portal hypertension, splenomegaly, treatment noncompliance, varices oesophageal, vein disorder.

4991255-3 | Alcoholism, Asterixis, Atelectasis, Cardiac Murmur, Cognitive Disorder, Dyspnoea, Gynaecomastia, Haemorrhoids
on Apr 13, 2006 Male patient from UNITED STATES , 30 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: alcoholism (What is alcoholism?), asterixis, atelectasis, cardiac murmur, cognitive disorder, dyspnoea, gynaecomastia, haemorrhoids. Cystagon dosage: Oral.

4867478-0 | Biopsy Stomach Abnormal, Erosive Duodenitis
on Dec 11, 2005 Female patient from UNITED STATES , child 4 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: biopsy stomach abnormal, erosive duodenitis. Cystagon dosage: .

4823471-5 | Ascites, Caput Medusae, Depression, Gastric Varices, Haemodialysis, Hepatic Encephalopathy, Hepatomegaly, Kidney Transplant Rejection, Multi-organ Failure
Patient was taking Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: ascites, caput medusae, depression (What is depression?), gastric varices, haemodialysis, hepatic encephalopathy, hepatomegaly, kidney transplant rejection, multi-organ failure on Nov 03, 2005 from UNITED STATES Additional patient health information: Male patient , 26 years of age, weighting 121.0 lb, was diagnosed with cystinosis and. Cystagon dosage: Po.

4796612-6 | Amyotrophy, Anaemia, Asthenia, Atrophy, Blood Urea Increased, Corneal Deposits, Creatinine Renal Clearance Decreased, Diabetes Mellitus, Dysphagia
Adverse event was reported on Sep 25, 2005 by a Male patient taking Cystagon (View Usage) (Dosage: 250 Mg; Q6h; Po) was diagnosed with cystinosis and. Location: , 20 years of age, Patient experienced the following unwanted or unexpected effects: amyotrophy, anaemia, asthenia, atrophy, blood urea increased, corneal deposits, creatinine renal clearance decreased, diabetes mellitus, dysphagia.

4745382-6 | Anuria, Ascites, Echocardiogram Abnormal, Gastric Varices, Haemodialysis, Hepatomegaly, Portal Hypertension, Portal Vein Thrombosis, Renal Transplant
on Jul 31, 2005 Male patient from UNITED STATES , 26 years of age, weighting 121.0 lb, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient had the following side effects: anuria, ascites, echocardiogram abnormal, gastric varices, haemodialysis, hepatomegaly, portal hypertension, portal vein thrombosis, renal transplant. Cystagon dosage: Po.

4675221-3 | Bone Disorder, Mass, Skin Lesion
on Apr 21, 2005 Male patient from , child 5 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: bone disorder, mass, skin lesion. Cystagon dosage: 110mg/kg/d Then 90mg/kg/d, Then 79mg/kg/d, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NUTROPIN (View Nutropin Review and Nutropin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), CARNITINE (View Carnitine Review and Carnitine Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), CYSTEAMINE EYE DROPS (View Cysteamine Eye Drops Review and Cysteamine Eye Drops Label ).

4650531-4 | Mass, Skin Lesion
Patient was taking Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: mass, skin lesion on Apr 21, 2005 from Additional patient health information: Male patient , child 5 years of age, was diagnosed with cystinosis and. Cystagon dosage: 110mg/kg/d Then 90mg/kg/d, Then 79mg/kg/d, Oral. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NUTROPIN (View Nutropin Review and Nutropin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), CARNITINE (View Carnitine Review and Carnitine Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), CYSTEAMINE EYE DROPS (View Cysteamine Eye Drops Review and Cysteamine Eye Drops Label ).

4650525-9 | Blood Glucose Increased, Bone Disorder, Mass, Myopathy, Skin Lesion
Adverse event was reported on Feb 15, 2005 by a Female patient taking Cystagon (View Usage) (Dosage: 90 Mg/kg/day, Then 53mg/kg/d, Oral) was diagnosed with cystinosis and. Location: , child 11 years of age, Patient had the following side effects: blood glucose increased, bone disorder, mass, myopathy, skin lesion. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), INSULIN ISOPHANE (View Insulin Isophane Review and Insulin Isophane Label ), SOMATROPINE (View Somatropine Review and Somatropine Label ), CALCIDOL (View Calcidol Review and Calcidol Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), SACCHARATED IRON OXIDE (View Saccharated Iron Oxide Review and Saccharated Iron Oxide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RIBOFLAVIN TAB (View Riboflavin Tab Review and Riboflavin Tab Label ).

4650517-X | Cerebral Ischaemia, Complement Factor C3 Decreased, Ehlers-danlos Syndrome, Lower Limb Fracture, Muscular Weakness, Osteopenia, Petechiae, Skin Lesion, Skin Striae
on Apr 21, 2005 Male patient from , child 9 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). After Cystagon was administered, patient had the following side effects: cerebral ischaemia, complement factor c3 decreased, ehlers-danlos syndrome (What is ehlers-danlos syndrome?), lower limb fracture, muscular weakness, osteopenia, petechiae, skin lesion, skin striae. Cystagon dosage: 400mg Qd, Then 600mg, Qd, Then 800mg Qd, Oral. During the same period patient was treated with CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ).

4650511-9 | Bone Pain, Collagen Disorder, Creatinine Renal Clearance Decreased, Ecchymosis, Knee Deformity, Rickets, Scoliosis, Skin Haemorrhage, Skin Lesion
on Feb 15, 2005 Male patient from , child 10 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, collagen disorder, creatinine renal clearance decreased, ecchymosis, knee deformity, rickets (What is rickets?), scoliosis, skin haemorrhage, skin lesion. Cystagon dosage: 55 Mg/kg; Qd; Po. During the same period patient was treated with CYSTEAMINE CHLORHYDRATE SYRUP (80 Mg/kg; Qd; Po) (View Cysteamine Chlorhydrate Syrup Review and Cysteamine Chlorhydrate Syrup Label ), THYROXIN (View Thyroxin Review and Thyroxin Label ), GROWTH HORMONE (View Growth Hormone Review and Growth Hormone Label ), EPOGEN (View Epogen Review and Epogen Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ).

4562155-8 | Cerebral Ischaemia, Coma, Complement Factor C3 Decreased, Compression Fracture, Convulsion, Difficulty In Walking, Hemiplegia, Lower Limb Fracture, Mass
Patient was taking Cystagon (View Usage). Patient had the following side effects: cerebral ischaemia, coma, complement factor c3 decreased, compression fracture, convulsion, difficulty in walking, hemiplegia, lower limb fracture, mass on Jan 10, 2005 from Additional patient health information: Male patient , child 9 years of age, was diagnosed with cystinosis and. Cystagon dosage: See Image.

4562152-2 | Skin Nodule
Adverse event was reported on Jan 10, 2005 by a Male patient taking Cystagon (View Usage) (Dosage: See Image) was diagnosed with cystinosis and. Location: , child 5 years of age, After Cystagon was administered, patient had the following side effects: skin nodule. During the same period patient was treated with LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), NUTROPIN (View Nutropin Review and Nutropin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), CARNITINE (View Carnitine Review and Carnitine Label ), POTASSIUM CITRATE (View Potassium Citrate Review and Potassium Citrate Label ), CYSTEAMINE EYE DROPS (View Cysteamine Eye Drops Review and Cysteamine Eye Drops Label ).

4562149-2 | Blood Glucose Increased, Dialysis, Mass, Myopathy, Osteosclerosis, Skin Lesion, Skin Nodule
on Jan 10, 2005 Female patient from , child 11 years of age, was diagnosed with cystinosis and was treated with Cystagon (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dialysis (What is dialysis?), mass, myopathy, osteosclerosis, skin lesion, skin nodule. Cystagon dosage: 90mg/kg/day, Then 53mg/kg/d, Oral. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), INSULIN ISOPHANE (View Insulin Isophane Review and Insulin Isophane Label ), SOMATROPINE (View Somatropine Review and Somatropine Label ), CALCIDIOL (View Calcidiol Review and Calcidiol Label ), EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), SACCHARATED IRON OXIDE (View Saccharated Iron Oxide Review and Saccharated Iron Oxide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), RIBOFLAVIN TAB (View Riboflavin Tab Review and Riboflavin Tab Label ).